Suchergebnisse - "Ma, Xiwen"

PubPharm (3)

1

A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma

enthalten in: American journal of hematology | 2022

von Cornell, R. | Baz, R. | Richter, J. | +23

2

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL) : a single-arm, multinational, multicentre, open-label, phase 2 trial

enthalten in: The Lancet. Haematology | 2020

von Kalakonda, N. | Maerevoet, M. | Cavallo, F. | +34

CommentIn: Lancet Haematol. 2020 Jul;7(7):e500-e501. - PMID 32589969

3

Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers

enthalten in: Cancer cell | 2015

von Peng, S. | Henry, J. | Kaufman, M. | +27

1
[1]